Hostname: page-component-cb9f654ff-rkzlw Total loading time: 0 Render date: 2025-07-31T10:53:25.228Z Has data issue: false hasContentIssue false
  • English
  • Français

Cardiac disease

Published online by Cambridge University Press:  17 November 2008

Douglas D Schocken
Douglas D Schocken*
Affiliation:
Division of Cardiology, University of South Florida Health Sciences Center, Tampa, USA
*
Douglas D Schocken, Associate Professor of Medicine, Interim Director, Division of Cardiology, MDC Box 19, 12901 Bruce B Downs Boulevard, Tampa, Florida 33612–4799, USA.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Clinical geriatrics
Information
Reviews in Clinical Gerontology , Volume 2 , Issue 3 , August 1992 , pp. 207 - 226
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1Parmley, WW.Pathophysiology and current therapy of congestive heart failure. J Am Coll Cardiol 1989; 13: 771–85.CrossRefGoogle ScholarPubMed
2Grossman, W.Diastolic dysfunction in congestive heart failure. N Engl J Med 1991; 325: 1557–64.Google ScholarPubMed
3Kannel, WB, Belanger, AJ.Epidemiology of heart failure. Am Heart J 1991; 121: 951–57.CrossRefGoogle ScholarPubMed
4Francis, GS, Cohn, JN.The autonomic nervous system in congestive heart failure. Annu Rev Med 1986; 37: 235–47.CrossRefGoogle ScholarPubMed
5Passik, CS, Ackerman, DM, Plut, H Jr, Edwards, WD.Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases. Mayo Clin Proc 1987; 62: 119–23.CrossRefGoogle ScholarPubMed
6Nestico, PF, Depace, NL, Morganroth, J, Kotler, MN, Ross, J.Mitral annular calcification: clinical, pathophysiology and echocardiographic review. Am Heart J 1984; 107: 989–96.CrossRefGoogle ScholarPubMed
7Terpenning, MS, Buggy, BP, Kaufman, CA.Infective endocarditis: clinical features in young and elderly patients. Am J Med 1987; 83: 626–34.CrossRefGoogle ScholarPubMed
8Rodeheffer, RJ, Gerstenblith, G, Becker, LC, Fleg, JL, Weisfeldt, ML, Lakatta, EG.Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilation and increased stroke volume compensate for a diminished heart rate. Circulation 1984; 69: 203–209.CrossRefGoogle ScholarPubMed
9Miyatake, K, Okamoto, M, Kinoshita, N et al. Augmentation of atrial contribution to left ventricular inflow with aging as assessed by intracardiac Doppler flowmetry. Am J Cardiol 1984; 53: 586–89.Google Scholar
10Wong, WF, Gold, S, Fukuyama, O, Blanchette, PL.Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol 1989; 63: 1526–28.CrossRefGoogle ScholarPubMed
11Kuo, LC, Quinones, MA, Rokey, R, Sartori, M, Abinader, EG, Zoghbi, WA.Quantification of a trial contribution to left ventricular filling by pulsed dopper echocardiograph and the effect of age in normal and diseased heartS. Am J Cardiol 1987; 59: 1174–78.CrossRefGoogle Scholar
12Kannel, WB, Castelli, WP, McNamara, PM, McKee, PA, Feinleib, M.The role of blood pressure in the development of congestive heart failure. N Engl J Med 1972; 287: 781–87.CrossRefGoogle ScholarPubMed
13Topol, EJ, Traill, TA, Fortuin, NJ.Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985; 312: 277–83.CrossRefGoogle ScholarPubMed
14Whiting, RB, Powell, WJ, Dinsmore, RE et al. Idiopathic hypertrophic subaortic stenosis in the elderly. N Engl J Med 1971; 285: 196–200.Google Scholar
15Lever, HM, Karam, RF, Currie, PJ, Healy, BP.Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. Circulation 1989; 79: 580–89.CrossRefGoogle Scholar
16Shenoy, MM, Khanna, A, Nejat, M, Greif, E, Friedman, SA.Hypertrophic cardiomyopathy in the elderly. A frequently misdiagnosed disease. Arch Intern Med 1986; 146: 658–61.CrossRefGoogle ScholarPubMed
17Fay, WP, Taliercio, CP, Ilstrup, DM, Tajik, AJ, Gersh, BJ.Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol 1990; 16: 821–26.CrossRefGoogle ScholarPubMed
18Spodick, DH, Quarry-Poigott, VM.Fourth heart sound as a normal finding in older persons. N Engl J Med 1973; 288: 140–41.CrossRefGoogle ScholarPubMed
19Levy, D, Labib, SB, Anderson, KM, Christiansen, JC, Kannel, WB, Castelli, WP.Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990; 81: 815–20.CrossRefGoogle ScholarPubMed
20Matsuzaki, M, Toma, Y, Kusukawa, R.Clinical applications of transesophageal echocardiography. Circulation 1990; 82: 709–22.CrossRefGoogle ScholarPubMed
21Soufer, R, Wohlagelemer, D, Vita, NA et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985; 55: 1032–36.Google Scholar
22Cohn, JN, Levine, TB, Olivari, MT et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819–23.Google Scholar
23Goldsmith, SR, Francis, GS, Cowley, AW et al. Increased plasma arginine vasopressin in patients with congestive heart failure. J Am Coll Cardiol 1983; 1: 1385–90.Google Scholar
24Packer, M, Lee, WH, Kessler, PD et al. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation 1987; 75: (suppl IV): IV80–92.Google Scholar
25Cohn, JN, Archibald, DG, Ziesche, S et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration co-operative study. N Engl J Med 1986; 314: 1547–52.Google Scholar
26The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429–35.CrossRefGoogle Scholar
27SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293–302.CrossRefGoogle Scholar
28Cohn, JN, Johnson, G, Ziesche, S et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. NEngl JMed 1991; 325: 303–10.Google Scholar
29Franciosa, JA, Jordan, RA, Wilen, MM et al. Minoxidil in patients with left heart failure: contrasting hemodynamic and clinical effects in a controlled trial. Circulation 1984; 70: 63–69.Google Scholar
30Markham, RV, Corbett, JR, Gilmore, A et al. Efficacy of prazosin in the management of chronic congestive heart failure: a 6 month randomized double blind, placebo-controlled study. Am J Cardiol 1983; 51: 1346–52.Google Scholar
31Miller, AB, Conetta, SA, Bass, TA.Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 1985; 55: 1359–62.CrossRefGoogle ScholarPubMed
32Walsh, RW, Porter, CB, Starling, MR et al. Beneficial hemodynamic effects of intravenous and oral diltiazem on severe congestive heart failure. J Am Coll Cardiol 1984; 3: 1044–50.Google Scholar
33Francis, GS.Calcium channel blockers and congestive heart failure. Circulation 1991; 83: 336–38.CrossRefGoogle ScholarPubMed
34Packer, M.Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure. Circulation 1989; 80 (suppl IV): IV59–67.Google ScholarPubMed
35Sica, DA, Gher, T. Diuretics in congestive heart failure. Cardiol Clin 1989; 7: 87–97.CrossRefGoogle ScholarPubMed
36Keermans, ALM, Tan, Y, Vanbaars, H, Van Ginmneken, GAM, Gribeau, FWJ.Furosemide kinetics and dynamics in aged patients. Clin Pharmacol Ther 1983; 34: 181–89.CrossRefGoogle Scholar
37Chaudry, AY, Bing, RF, Castleden, CM, Swales, JD, Napier, CJ.The effect of aging on the response to furosemide in normal subjects. Eur J Clin Pharmacol 1984; 27: 303–306.CrossRefGoogle Scholar
38Kulick, DL, Rahmatoola, SH.Current role of digitalis therapy in patients with congestive heart failure. JAMA 1991; 265: 2995–97.CrossRefGoogle ScholarPubMed
39Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988; 259: 539–44.CrossRefGoogle Scholar
40Reg, JL, Gottlieb, SH, Lakatta, EG.Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm. Am J Med 1982; 73: 244–50.Google Scholar
41Liang, CS, Sherman, LG, Doherty, JU, Wellington, K, Lee, VW, Hood, WB Jr.Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine. Circulation 1984; 69: 113–19.CrossRefGoogle ScholarPubMed
42Rich, MW, Imburgia, M. Inotropic response to dobutamine in elderly patients with decompensated heart failure. Am J Cardiol 1990; 65: 519–21.CrossRefGoogle Scholar
43Packer, M, Carver, JR, Rodeheffer, RJ et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Eng U Med 1991; 325: 1468–75.Google Scholar
44Edmunds, LH Jr, Stephenson, LW, Edie, RN, Ratcliffe, MB. Open-heart surgery in octogenarians. N Engl J Med 1988; 319: 131–36.CrossRefGoogle ScholarPubMed
45Naunheim, KS, Dean, PA, Fiore, AC et al. Cardiac surgery in the octogenarian. Eur J Cardio-thoracSurg 1990; 4: 130–35.Google Scholar
46Freeman, WK, Schaff, HV, O'brien, PC, Orszulak, TA, Naessens, JM, Tajik, AJ.Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol 1991; 18: 29–35.CrossRefGoogle ScholarPubMed
47Cribier, A, Savin, T, Berland, J et al. Percutaneous transluminal balloon valvuloplasty of adult aortic stenosis: report of 92 cases. J Am Coll Cardiol 1987; 9: 381–86.Google Scholar
48Safian, RD, Berman, AD, Diver, DJ et al. Balloon aortic valvuloplasty in 170 consecutive patients. N Eng U Med 1988; 319: 125–30.Google Scholar
49Abascal, VM, Wilkins, ET, O'shea, JP et al. Prediction of successful outcome in 130 patientsundergoing percutaneous balloon mitral valvotomy. Circulation 1990; 82: 448–56.Google Scholar
50Herrmann, HC, Kleaveland, JP, Hill, JA et al. The M-Heart Percutaneous Balloon Mitral Valvuloplasty Registry: initial results and early follow-up. J Am Coll Cardiol 1990; 15: 1221–26.Google Scholar
51Palacios, IF, Block, PC, Wilkins, ET, Weyman, AE.Follow-up of patients undergoing percutaneous mitral balloon valvotomy: analysis of factors determining restenosis. Circulation 1989; 79: 573–79.CrossRefGoogle ScholarPubMed
52Litvack, F, Jakubowski, AT, Buchbinder, NA, Eigler, N.Lack of sustained improvement in an elderly population after percutaneous aortic valvuloplasty. Am J Cardiol 1988; 62: 270–75.CrossRefGoogle Scholar
53Fleg, JL, Kennedy, HL.Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest 1982; 81: 302–307.CrossRefGoogle Scholar
54Kantelop, JP, Sage, E, Duchene-Marallaz, P.Findings in ambulatory electrocardiographic monitoring in subjects older than 80 years. Am J Cardiol 1986; 57: 398–401.CrossRefGoogle Scholar
55Camm, AJ, Evans, KE, Ward, DE, Martin, A.The rhythm of the heart in active elderly subjects. Am Heart J 1980; 99: 598–603.CrossRefGoogle ScholarPubMed
56Kannel, WB, Abbott, RD, Savage, DD, McNamara, PM.Epidemiologic features of chronic atrial fibrillation: The Framingham Study. N Eng U Med 1982; 306: 1018–22.CrossRefGoogle ScholarPubMed
57Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neural 1986; 43: 71–84.CrossRefGoogle Scholar
58Wolf, PA, Abbott, RD, Kannel, WB.Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983–88.CrossRefGoogle ScholarPubMed
59Petersen, P, Boysen, G, Gotfredsen, J, Andersen, ED, Andersen, B.Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1989; 1: 175–79.CrossRefGoogle ScholarPubMed
60Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 1991; 84: 527–39.CrossRefGoogle Scholar
61The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Eng U Med 1990; 323: 1505–11.CrossRefGoogle Scholar
62Platia, EV, Michelson, EL, Porterfield, JK, Das, G.Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol 1989; 63: 925–29.CrossRefGoogle ScholarPubMed
63Waxman, HL, Myerburg, RJ, Appel, R, Sung, RJ.Verapamil for control of ventricular rate of paroxysmal supraventricular tachycardia and atrial fibrillation or flutter. A double-blind randomized cross-over study. Ann Intern Med 1981; 94: 1–6.CrossRefGoogle ScholarPubMed
64Ditrich, HC, Erickson, JS, Schneiderman, T, Blacky, AR, Savides, T, Nicod, PH.Echocardiographic predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989; 63: 193–97.CrossRefGoogle Scholar
65Brodsky, MA, Allen, BJ, Capparelli, EV, Luckett, CR, Morton, R, Henry, WL.Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol 1989; 63: 1065–68.CrossRefGoogle ScholarPubMed
66Hoglund, C, Rosenhamer, G.Echocardiographic left atrial dimension as a predictor of maintaining sinus rhythm after conversion of atrial fibrillation. Acta Med Scand 1985; 217: 411–15.CrossRefGoogle ScholarPubMed
67McLenachan, JM, Henderson, E, Morris, KL, Dargie, HJ.Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Eng U Med 1987; 317: 787–92.CrossRefGoogle ScholarPubMed
68Messerli, FH, Ventura, HO, Elizardi, DG, Drelinski, GR, Dunn, FG, Frohlich, ED.Hypertension and sudden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984; 77: 18–22.CrossRefGoogle ScholarPubMed
69Parmley, WW, Chatterjee, K.Congestive heart failure and arrhythmias: an overview. Am J Cardiol 1986; 57: 34–378.CrossRefGoogle ScholarPubMed
70The CAST Investigators. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmic suppression after myocardial infarction. N Engl J Med 1989; 321: 406–12.CrossRefGoogle Scholar
71Pratt, CM, Delclos, G, Wierman, AM et al. The changing baseline of complex ventricular arrhythmias: a new consideration in assessing long-term antiarrhythmic drug therapy. N Engl J Med 1985; 313: 1444–49.Google Scholar
72Toivomen, L.Spontaneous variability in the frequency of ventricular premature complexes over prolonged intervals and implications for antiarrhythmic treatment. Ami Cardiol 1987; 60: 608–12.CrossRefGoogle Scholar
73Shibata, T, Kubota, I, Ikeda, K, Tsuiki, K, Yasui, S.Body surface mapping of high frequency components in the terminal portion during QRS complex for the prediction of ventricular tachycardia in patients with previous myocardial infarction. Circulation 1990; 82: 2084–92.CrossRefGoogle ScholarPubMed
74Wellens, HJJ, Brusader, P, Stevenson, WG.Programmed electrical stimulation of the heart in patients with life threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation 1985; 72: 1–7.CrossRefGoogle ScholarPubMed
75Kastor, JA, Horowitz, LN, Harken, AH, Josephson, ME.Clinical electrophysiology of ventricular tachycardia. N Engl J Med 1981; 304: 1004–20.CrossRefGoogle ScholarPubMed
76Tresch, DD, Troup, PJ, Thaker, RK et al. Comparison of efficacy of automatic implantable cardioverter defibrillator in patients older and younger than 65 years of age. Am J Med 1991; 90: 717–24.Google Scholar
77Singh, BN, Kaplinsky, E, Kirsten, E, Guerrero, J.Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study. Am Heart J 1988; 116: 1542–51.CrossRefGoogle ScholarPubMed
78Kowey, PR, Stohler, JL, Friehling, TD, Marinchak, RA.Propafenone in the treatment of patients with malignant ventricular tachyarrhythmias. Can J Cardiol 1991; 7: 175–80.Google ScholarPubMed
79Gonzalez, R, Scheinman, MM, Herre, JM, Griffin, JC, Sauve, MJ, Sharkey, H.Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias. Am Coll Cardiol 1988; 12: 1568–72.CrossRefGoogle ScholarPubMed
80Kehoe, RF, Zheutlin, TA, Dunnington, CS, Mattini, TA, Yu, G, Spangenberg, RB.Safety and efficacy of sotalol in patients with drug-refractory sustained ventricular tachyarrhythmias. Am J Cardiol 1990; 65: 58–64A.CrossRefGoogle ScholarPubMed
81Nademanee, K, Singh, BN, Hendrickson, J et al. Amodarone in refractory life-threatening ventricular arrhythmias. Ann Intern Med 1983; 98: 577–84.Google Scholar
82McGovern, B, Garan, H, Malacoff, RF et al. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. Am J Cardiol 1984: 53: 1558–63.Google Scholar
83Kulbertus, HE, Deleval-Turren, F, Demoulin, JC.Sinoatrial disease: a report on 13 cases. J Electrocardiol 1973; 6: 303–12.CrossRefGoogle ScholarPubMed
84World Survey on Cardiac Pacing (1981). PACE 1983; 6: A157–172.Google Scholar
85Rokseth, R, Hattle, L.Sinus arrest in acute myocardial infarction. Br Heart J 1971; 33: 639–42.CrossRefGoogle ScholarPubMed
86Shaw, DB, Linker, NJ, Heaver, PA, Evans, I.Chronic sinoatrial disorder (sick sinus syndrome) a possible result of cardiac ischemia. Br Heart J 1987; 53: 598–607.CrossRefGoogle Scholar
87Jose, AD, Collison, D.The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res 1970; 4: 160–67.CrossRefGoogle ScholarPubMed
88Johnston, FA, Robinson, JF, Fyfe, T.Exercise testing in the diagnosis of sick sinus syndrome in the elderly: implications for treatment. PACE 1987; 10: 831–38.CrossRefGoogle ScholarPubMed
89Benditt, DG, Garnick, CC, Dunbar, D, Almquist, A, Pool-Schneider, S.Indications for electrophysiologic testing in the diagnosis and assessment of sinus node dysfunction. Circulation 1987; 75: (suppl 3, pt II): 11193–99.Google ScholarPubMed
90Cain, ME.Electrophysiologic assessment of sinus node function. Circulation 1987; 75: (suppl 3, pt II): III100–102.Google Scholar
91Yee, R, Strauss, HC.Electrophysiologic mechanisms: sinus node dysfunction. Circulation 1987; 75: (suppl 3, pt II): III12–18.Google ScholarPubMed
92Viersma, JW, Van Den Bers, MD, Van-Gilst, WH, Lie, KI.Intrinsic sympatholmimetic activity (ISA) of pindolol in patients with sinus node dysfunction. Eur Heart J 1986; 7: 42–46.CrossRefGoogle ScholarPubMed
93Lippestade, CT, Forfang, K.Production of sinus arrest by lignocaine. Br Med J 1971; 1: 537.CrossRefGoogle Scholar
94Lemke, B, Holtman, BJ, Selbach, H, Barmeyer, J.The atrial pacemaker: retrospective analysis of complications and life expectancy in patients with sinus node dysfunction. Int J Cardiol 1989; 22: 185–93.CrossRefGoogle ScholarPubMed
95Mitsuoka, T, Kenny, RA, Yeung, TA, Chan, SL, Perrins, JE, Sutton, R.Benefits of dual-chamber pacing in sick sinus syndrome. Br Heart J 1988; 60: 338–47.CrossRefGoogle ScholarPubMed
96Rediker, DE, Eagle, KA, Homma, S, Gillam, LD, Harthorne, JW.Clinical and hemodynamic comparison of WI versus DDD pacing in patients with DDD pacemakers. Am J Cardiol 1988; 61: 323–92.CrossRefGoogle Scholar
97Sasaki, Y, Shimotori, M, Akahane, K et al. Long-term follow-up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced and physiologically paced groups. PACE 1988; 11: 1575–83.Google Scholar
98Morgan, JM, Joseph, SP, Bahri, AK, Ramdial, J, Crowthar, A.Choosing the pacemaker; a rational approach to the use of modern pacemaker technology. Ear Heart J 1990; 11: 753–64.CrossRefGoogle Scholar
99Breivik, K, Ohm, OJ, Segadal, L.Sick sinus syndrome treated with permanent pacemaker in 109 patients. A follow-up study. Acta Med Scand 1979; 206: 153–59.CrossRefGoogle ScholarPubMed
100Alt, E, Volker, R, Wirtzfeld, A, Ulm, K.Survival and follow-up after pacemaker implantation: a comparison of patients with sick sinus syndrome, complete heart block and atrial fibrillation. PACE 1985; 8: 849–55.CrossRefGoogle ScholarPubMed